# Bibliometric analysis of neonatal sepsis from 2002 to 2022

## TL;DR

This study maps neonatal sepsis research trends from 2002 to 2022, highlighting key contributors and future directions.

## Contribution

The first bibliometric analysis of neonatal sepsis research, revealing global trends and future research priorities.

## Key findings

- The number of publications on neonatal sepsis increased yearly, with the USA and Duke University as leading contributors.
- Research focused on pathogens, diagnosis, and management, with future emphasis on novel biomarkers and antibiotic use.
- Pediatric Infectious Disease Journal and author BASU S were the most productive in the field.

## Abstract

This study aimed to visualize the knowledge structure and research trends in neonatal sepsis research through bibliometric methods. Articles and reviews regarding neonatal sepsis from 2002 to 2022 were retrieved from the Web of Science Core Collection database. CiteSpace software was used to visualize the knowledge network of countries/regions, institutions, authors, journals, keywords, and references in this field. Altogether, 2314 publications were identified. During the study period, the number of publications increased yearly. The USA is the leading country in neonatal sepsis research. Duke University was the most prolific institution, with Pediatric Infectious Disease Journal and BASU S being the most prolific journal and author in the field, respectively. Pathogen, diagnosis, and management were the main topics of research, and future studies may concentrate on novel diagnostic biomarkers and judicious use of antibiotics. In summary, the results of our bibliometric analysis revealed views on the current situation and trends of neonatal sepsis research for the first time. This study may provide guidance for promoting research on neonatal sepsis.

The USA and Duke University were the leading contributors in neonatal sepsis research. The Pediatric Infectious Disease Journal and author BASU S had the highest productivity. Research primarily focused on pathogens, diagnosis, and management. Future studies may prioritize novel diagnostic biomarkers and the appropriate use of antibiotics.